Results 1 - 10 of 198 : 1 2 3 4 5 6 7 8 9 Next
Newsflash: Emerging Markets Aren't Safe Havens
Wait, are they serious?
Biotech Investors' Dream Stocks
The best biotech stocks are within your reach.
Maybe You Can Bail Out the Banks
Why look to the government when you can chip in $700 billion?
Amgen Draws Blood in Anemia-Drug War
The pharmaceutical fights off rival Roche.
Will Johnson & Johnson Ever Get Its Money?
Boston Scientific and Medtronic owe the company money, but will they pay up?
5-Star Stocks Poised to Pop: Teva Pharmaceutical
Market-trouncing returns could be written in this 5-star.
A Top BioMarin Drug Heads Overseas
BioMarin's Kuvan is tentatively given the thumbs up in Europe.
A nod from the FDA and a new partnership boost Indevus shares. Where to, now?
It's conquering the world, slowly but surely. But is it still a value play?
Extended Look at an Extended-Release Drug
The FDA is still investigating Teva's generic Wellbutrin XL.
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK